The human crisis in cancer: a Lancet Oncology Commission.

Despite overall survivaloutcomes improving, the systems designed to deliver care increasingly fall short in addressing the emotional, relational, and existential dimensions of cancer.

尽管总生存结果有所改善，但旨在提供护理的系统在解决癌症的情感、关系和存在维度方面越来越不足。

Although examples of compassionate and attentive care can be found in every setting, patients and families across global contexts continue to report being unheard, unsupported, and, at times, actively harmed by care structures that prioritise technical precision over human presence.

尽管在每个环境中都可以找到富有同情心和关注的护理例子，但全球范围内的患者和家庭继续报告他们被忽视、缺乏支持，有时甚至被优先考虑技术精确度而非人的存在的护理结构所积极伤害。

This Lancet Oncology Commission proposes that the human crisis of cancer is not defined by pathology, mortality, or cause, but by the erosion of meaning, connection, and compassion in the experience of cancer.

这本《柳叶刀肿瘤学》委员会提出，癌症的人类危机并非由病理、死亡率或原因定义，而是由在癌症经历中意义、联系和同情心的侵蚀所定义。

This crisis is shaped by what is present and what is absent: the presence of fragmented, costly, and impersonal systems and the absence of human connection, psychological safety, and relational care.

这场危机的形成是由存在的和缺失的因素共同塑造的：存在的是支离破碎、成本高昂且缺乏人情味的系统，而缺失的则是人际联系、心理安全感和关系护理。

It is a crisis that spans delivery, mental health, palliative care, research, and education-one that is not peripheral to oncology's progress but central to its failures.

这是一个涉及医疗交付、心理健康、姑息治疗、研究和教育的危机——它不是肿瘤学进步的边缘问题，而是其失败的核心问题。

The impacts of this crisis are felt most acutely by those already made vulnerable by inequity, discrimination, and economic precarity, but it is a system-level failure that ripples across every context, from the most resource-rich to the most resource-constrained settings.

这场危机的影响最深刻地被那些已经因不平等、歧视和经济不稳定而变得脆弱的人所感受到，但它是一个系统级的失败，波及到每一个环境，从资源最丰富的到资源最匮乏的环境。

Addressing this crisis will require more than good intentions; it will demand confronting the structural incentives and ideologies that have devalued the relational foundations of cancer care.

解决这一危机将需要的不仅仅是良好的意愿；它将要求面对那些已经贬低了癌症护理关系基础的结构性激励和意识形态。

This Commission identifies a growing imbalance between technological innovation and the human dimensions of cancer care.

该委员会指出了技术创新与癌症护理人性化方面日益增长的不平衡。

As the field has increasingly prioritised biopharmaceutical development, genomic precision, and market-driven efficiencies, it has often neglected core practices that uphold dignity, alleviate suffering, and build trust.

随着领域越来越重视生物制药开发、基因组精准度和市场驱动的效率，常常忽视了维护尊严、减轻痛苦和建立信任的核心实践。